Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
Lifevantage股價上漲，因爲公司宣佈成功完成了爲期12周的新GLP-1系統用於減肥的臨床試驗。
Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
lifevantage股價上漲，公司宣佈其新GLP-1減肥系統成功完成12周臨床試驗。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。